Non-apoptotic cell death in malignant tumor cells and natural compounds

Cancer Letters

Volumn 420, Issue , 2018, Pages 210-227

  Ye, Jing ^a   Zhang, Ruonan ^b,c   Wu, Fan ^d   Zhai, Lijuan ^b,c   Wang, Kaifeng ^b,c   Xiao, Mang ^a   Xie, Tian ^b,c   Sui, Xinbing ^b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c HANGZHOU NORMAL UNIVERSITY   (China)

^d Des Moines Public Schools   (United States)

Author keywords

Cancer; Natural compounds; Non apoptotic cell death

Indexed keywords

ANDROGRAPHOLIDE; ARECA NUT EXTRACT; ARTEMISININ; BAICALEIN; BISINDOLIC ALKALOID VOACAMINE; CARBAZOLE ALKALOID; CEAROIN; CIMIGENOL; COTYLENIN A; CRANBERRY EXTRACT; DEHYDROANDROGRAPHOLIDE; DOCOSAHEXAENOIC ACID; ESCULETIN; FLAVONOID; FLAVONOL FISETIN; GINSENOSIDE RH 2; GLABRIDIN; KY 17; LECTIN; MATRINE; MORIN; NATURAL PRODUCT; PHOSPHATIDYLINOSITOL 3 KINASE; PLATYCODIN D; POLYPHYLLIN G; PROANTHOCYANIDIN DERIVATIVE; RESVERATROL; SAPONIN XA 2; SHIKONIN; STEROIDAL SAPONIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; BIOLOGICAL PRODUCT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CELL PROTECTION; DOWN REGULATION; EXOSOME ASSOCIATED CELL DEATH; FERROPTOSIS; G2 PHASE CELL CYCLE CHECKPOINT; GLUTAMOPTOSIS; HUMAN; NECROPTOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYROPTOSIS; REGULATORY MECHANISM; SHORT SURVEY; CELL DEATH; CHEMISTRY; DRUG EFFECT; EXOSOME; METABOLISM; NEOPLASM; TUMOR CELL LINE;

BIOLOGICAL PRODUCTS; CELL DEATH; CELL LINE, TUMOR; EXOSOMES; HUMANS; NEOPLASMS;

EID: 85042429525     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2018.01.061     Document Type: Review

References (181)

1. Tan, M.L., Ooi, J.P., Ismail, N., Moad, A.I., Muhammad, T.S., Programmed cell death pathways and current antitumor targets. Pharm. Res. 26 (2009), 1547–1560.
2. Tait, S.W., Ichim, G., Green, D.R., Die another way–non-apoptotic mechanisms of cell death. J. Cell Sci. 127 (2014), 2135–2144.
3. Narayanan, K.B., Ali, M., Barclay, B.J., Cheng, Q.S., D'Abronzo, L., Dornetshuber-Fleiss, R., Ghosh, P.M., Gonzalez, G.M., Lee, T.J., Leung, P.S., Li, L., Luanpitpong, S., Ratovitski, E., Rojanasakul, Y., Romano, M.F., Romano, S., Sinha, R.K., Yedjou, C., Al-Mulla, F., Al-Temaimi, R., Amedei, A., Brown, D.G., Ryan, E.P., Colacci, A., Hamid, R.A., Mondello, C., Raju, J., Salem, H.K., Woodrick, J., Scovassi, A.I., Singh, N., Vaccari, M., Roy, R., Forte, S., Memeo, L., Kim, S.Y., Bisson, W.H., Lowe, L., Park, H.H., Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death. Carcinogenesis 36:Suppl 1 (2015), S89–S110.
4. Imai, H., Matsuoka, M., Kumagai, T., Sakamoto, T., Koumura, T., Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis. Curr. Top. Microbiol. Immunol. 403 (2017), 143–170.
5. Bergsbaken, T., Fink, S.L., Cookson, B.T., Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7 (2009), 99–109.
6. Ha, D., Yang, N., Nadithe, V., Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm. Sin. B 6 (2016), 287–296.
7. Guaman-Ortiz, L.M., Orellana, M.I., Ratovitski, E.A., Natural compounds as modulators of non-apoptotic cell death in cancer cells. Curr. Genom. 18 (2017), 132–155.
8. Galluzzi, L., Pietrocola, F., Bravo San Pedro, J.M., Amaravadi, R.K., Baehrecke, E.H., Cecconi, F., Codogno, P., Debnath, J., Gewirtz, D.A., Karantza, V., Kimmelman, A., Kumar, S., Levine, B., Maiuri, M.C., Martin, S.J., Penninger, J., Piacentini, M., Rubinsztein, D.C., Simon, H.U., Simonsen, A., Thorburn, A.M., Velasco, G., Ryan, K.M., Kroemer, G., Autophagy in malignant transformation and cancer progression., 34, 2015, 856–880.
9. Guo, J.Y., White, E., Autophagy, metabolism, and cancer. Cold Spring Harbor Symp. Quant. Biol. 81 (2016), 73–78.
10. Kroemer, G., Marino, G., Levine, B., Autophagy and the integrated stress response. Mol. Cell. 40 (2010), 280–293.
11. Zhao, Y., Qu, T., Wang, P., Li, X., Qiang, J., Xia, Z., Duan, H., Huang, J., Zhu, L., Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy. Apoptosis 21 (2016), 517–531.
12. Chen, Y.F., Liu, H., Luo, X.J., Zhao, Z., Zou, Z.Y., Li, J., Lin, X.J., Liang, Y., The roles of reactive oxygen species (ROS) and autophagy in the survival and death of leukemia cells. Crit. Rev. Oncol. Hematol. 112 (2017), 21–30.
13. Wang, S.F., Wu, M.Y., Cai, C.Z., Li, M., Lu, J.H., Autophagy modulators from traditional Chinese medicine: mechanisms and therapeutic potentials for cancer and neurodegenerative diseases. J. Ethnopharmacol. 194 (2016), 861–876.
14. Liu, Y.L., Yang, P.M., Shun, C.T., Wu, M.S., Weng, J.R., Chen, C.C., Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. Autophagy 6 (2010), 1057–1065.
15. Mizushima, N., Yoshimori, T., Ohsumi, Y., The role of Atg proteins in autophagosome formation. Annu. Rev. Cell Dev. Biol. 27 (2011), 107–132.
16. Kroemer, G., Levine, B., Autophagic cell death: the story of a misnomer. Nat. Rev. Mol. Cell Biol. 9 (2008), 1004–1010.
17. Panda, P.K., Mukhopadhyay, S., Das, D.N., Sinha, N., Naik, P.P., Bhutia, S.K., Mechanism of autophagic regulation in carcinogenesis and cancer therapeutics. Semin. Cell Dev. Biol. 39 (2015), 43–55.
18. Shinojima, N., Yokoyama, T., Kondo, Y., Kondo, S., Roles of the Akt/mTOR/p70S6K and ERK1/2 signaling pathways in curcumin-induced autophagy. Autophagy 3 (2007), 635–637.
19. Roy, B., Pattanaik, A.K., Das, J., Bhutia, S.K., Behera, B., Singh, P., Maiti, T.K., Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells. Chem. Biol. Interact. 210 (2014), 96–102.
20. Noda, T., Ohsumi, Y., Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273 (1998), 3963–3966.
21. Alexander, A., Cai, S.L., Kim, J., Nanez, A., Sahin, M., MacLean, K.H., Inoki, K., Guan, K.L., Shen, J., Person, M.D., Kusewitt, D., Mills, G.B., Kastan, M.B., Walker, C.L., ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 4153–4158.
22. Lee, E.J., Tournier, C., The requirement of uncoordinated 51-like kinase 1 (ULK1) and ULK2 in the regulation of autophagy. Autophagy 7 (2011), 689–695.
23. Laddha, S.V., Ganesan, S., Chan, C.S., White, E., Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Canc. Res. 12 (2014), 485–490.
24. Bjorkoy, G., Lamark, T., Pankiv, S., Overvatn, A., Brech, A., Johansen, T., Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 452 (2009), 181–197.
25. Ranjan, A., Iwakuma, T., Non-Canonical cell death induced by p53. Int. J. Mol. Sci., 17, 2016, 2068.
26. Maiuri, M.C., Malik, S.A., Morselli, E., Kepp, O., Criollo, A., Mouchel, P.L., Carnuccio, R., Kroemer, G., Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8 (2009), 1571–1576.
27. Maiuri, M.C., Criollo, A., Kroemer, G., Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J. 29 (2010), 515–516.
28. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S.C., Kamphorst, J.J., Strohecker, A.M., Chen, G., Price, S., Lu, W., Teng, X., Snyder, E., Santanam, U., Dipaola, R.S., Jacks, T., Rabinowitz, J.D., White, E., Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 27 (2013), 1447–1461.
29. Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V., Coller, H.A., Dipaola, R.S., Gelinas, C., Rabinowitz, J.D., White, E., Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25 (2011), 460–470.
30. Sun, H., Wang, Z., Yakisich, J.S., Natural products targeting autophagy via the PI3K/Akt/mTOR pathway as anticancer agents. Anticanc. Agents Med. Chem. 13 (2013), 1048–1056.
31. Wan, X.M., Zheng, F., Zhang, L., Miao, Y.Y., Man, N., Wen, L.P., Autophagy-mediated chemosensitization by cysteamine in cancer cells. Int. J. Canc. 129 (2011), 1087–1095.
32. Chen, S., Rehman, S.K., Zhang, W., Wen, A., Yao, L., Zhang, J., Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta 1806 (2010), 220–229.
33. Xu, X.D., Zhao, Y., Zhang, M., He, R.Z., Shi, X.H., Guo, X.J., Shi, C.J., Peng, F., Wang, M., Shen, M., Wang, X., Li, X., Qin, R.Y., Inhibition of autophagy by deguelin sensitizes pancreatic cancer cells to doxorubicin. Int. J. Mol. Sci., 18, 2017.
34. Wu, J., Kong, F., Pan, Q., Du, Y., Ye, J., Zheng, F., Li, H., Zhou, J., Autophagy protects against cholesterol-induced apoptosis in pancreatic beta-cells. Biochem. Biophys. Res. Commun. 482 (2017), 678–685.
35. Dai, X., Liu, J., Nian, Y., Qiu, M.H., Luo, Y., Zhang, J., A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells. Oncol. Rep. 37 (2017), 2079–2086.
36. Li, T., Tang, Z.H., Xu, W.S., Wu, G.S., Wang, Y.F., Chang, L.L., Zhu, H., Chen, X.P., Wang, Y.T., Chen, Y., Lu, J.J., Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells. Eur. J. Pharmacol. 749 (2015), 81–88.
37. Kim, M.O., Moon, D.O., Choi, Y.H., Lee, J.D., Kim, N.D., Kim, G.Y., Platycodin D induces mitotic arrest in vitro, leading to endoreduplication, inhibition of proliferation and apoptosis in leukemia cells. Int. J. Canc. 122 (2008), 2674–2681.
38. Yu, J.S., Kim, A.K., Platycodin D induces reactive oxygen species-mediated apoptosis signal-regulating kinase 1 activation and endoplasmic reticulum stress response in human breast cancer cells. J. Med. Food 15 (2012), 691–699.
39. Platycodin D triggers autophagy through activation of extracellular signal-regulated kinase in hepatocellular carcinoma HepG2 cells.
40. Yang, Y., Guo, J.X., Shao, Z.Q., Gao, J.P., Matrine inhibits bladder cancer cell growth and invasion in vitro through PI3K/AKT signaling pathway: an experimental study. Asian. Pac. J. Trop. Med. 10 (2017), 515–519.
41. Ma, K., Huang, M.Y., Guo, Y.X., Hu, G.Q., Matrine-induced autophagy counteracts cell apoptosis via the ERK signaling pathway in osteosarcoma cells. Oncol. Lett. 12 (2016), 1854–1860.
42. Xie, S.B., He, X.X., Yao, S.K., Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells. Int. J. Oncol. 47 (2015), 517–526.
43. Li, Y., Zhang, J., Ma, H., Chen, X., Liu, T., Jiao, Z., He, W., Wang, F., Liu, X., Zeng, X., Protective role of autophagy in matrineinduced gastric cancer cell death. Int. J. Oncol. 42 (2013), 1417–1426.
44. Wang, L., Gao, C., Yao, S., Xie, B., Blocking autophagic flux enhances matrine-induced apoptosis in human hepatoma cells. Int. J. Mol. Sci. 14 (2013), 23212–23230.
45. Li, Y., Zhang, J., Ma, H., Chen, X., Liu, T., Jiao, Z., He, W., Wang, F., Liu, X., Zeng, X., Protective role of autophagy in matrineinduced gastric cancer cell death. Int. J. Oncol. 42 (2013), 1417–1426.
46. Hsieh, M.J., Chen, M.K., Chen, C.J., Hsieh, M.C., Lo, Y.S., Chuang, Y.C., Chiou, H.L., Yang, S.F., Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells. Phytomedicine 23 (2016), 359–366.
47. Lu, H.H., Liu, C.J., Liu, T.Y., Kao, S.Y., Lin, S.C., Chang, K.W., Areca-treated fibroblasts enhance tumorigenesis of oral epithelial cells. J. Dent. Res. 87 (2008), 1069–1074.
48. Xu, Z., Huang, C.M., Shao, Z., Zhao, X.P., Wang, M., Yan, T.L., Zhou, X.C., Jiang, E.H., Liu, K., Shang, Z.J., Autophagy induced by areca nut extract contributes to decreasing cisplatin toxicity in oral squamous cell carcinoma cells: roles of reactive oxygen species/AMPK signaling. Int. J. Mol. Sci., 18, 2017.
49. Chen, Y.J., Chang, J.T., Liao, C.T., Wang, H.M., Yen, T.C., Chiu, C.C., Lu, Y.C., Li, H.F., Cheng, A.J., Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Canc. Sci. 99 (2008), 1507–1514.
50. Lin, M.H., Liu, S.Y., Liu, Y.C., Autophagy induction by a natural ingredient of areca nut. Autophagy 4 (2008), 967–968.
51. Ji, W.T., Lee, C.I., Chen, J.Y., Cheng, Y.P., Yang, S.R., Chen, J.H., Chen, H.R., Areca nut extract induces pyknotic necrosis in serum-starved oral cells via increasing reactive oxygen species and inhibiting GSK3beta: an implication for cytopathic effects in betel quid chewers. PLoS One, 8, 2013, e63295.
52. Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., Kroemer, G., Molecular mechanisms of cisplatin resistance. Oncogene 31 (2012), 1869–1883.
53. Weh, K.M., Howell, A.B., Kresty, L.A., Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma. Mol. Carcinog. 55 (2016), 1876–1885.
54. Kresty, L.A., Weh, K.M., Zeyzus-Johns, B., Perez, L.N., Howell, A.B., Cranberry proanthocyanidins inhibit esophageal adenocarcinoma in vitro and in vivo through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation. Oncotarget 6 (2015), 33438–33455.
55. Wang, R.C., Wei, Y., An, Z., Zou, Z., Xiao, G., Bhagat, G., White, M., Reichelt, J., Levine, B., Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science 338 (2012), 956–959.
56. Xu, X., Li, T., Fong, C., Chen, X., Chen, X., Wang, Y., Huang, M., Lu, J., Saponins from Chinese medicines as anticancer agents. Molecules, 21, 2016, 1326.
57. Xie, Z.Z., Li, M.M., Deng, P.F., Wang, S., Wang, L., Lu, X.P., Hu, L.B., Chen, Z., Jie, H.Y., Wang, Y.F., Liu, X.X., Liu, Z., Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem. Biol. Interact. 264 (2017), 1–9.
58. Yim, N.H., Hwang, Y.H., Liang, C., Ma, J.Y., A platycoside-rich fraction from the root of Platycodon grandiflorum enhances cell death in A549 human lung carcinoma cells via mainly AMPK/mTOR/AKT signal-mediated autophagy induction. J. Ethnopharmacol. 194 (2016), 1060–1068.
59. Hsieh, M.J., Chien, S.Y., Lin, J.T., Yang, S.F., Chen, M.K., Polyphyllin G induces apoptosis and autophagy cell death in human oral cancer cells Phytomedicine. Phytomedicine 23 (2016), 1545–1554.
60. Liu, S., Chen, M., Li, P., Wu, Y., Chang, C., Qiu, Y., Cao, L., Liu, Z., Jia, C., Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell. Physiol. Biochem. 36 (2015), 499–508.
61. Chen, J., Yuan, J., Zhou, L., Zhu, M., Shi, Z., Song, J., Xu, Q., Yin, G., Lv, Y., Luo, Y., Jia, X., Feng, L., Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway. Biomed. Pharmacother. 87 (2017), 118–126.
62. Smith, M.L., Murphy, K., Doucette, C.D., Greenshields, A.L., Hoskin, D.W., The dietary flavonoid Fisetin causes cell cycle arrest, caspase-dependent apoptosis, and enhanced cytotoxicity of chemotherapeutic drugs in triple-negative breast cancer cells. J. Cell. Biochem. 117 (2016), 1913–1925.
63. Suh, Y., Afaq, F., Khan, N., Johnson, J.J., Khusro, F.H., Mukhtar, H., Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis 31 (2010), 1424–1433.
64. Zhang, X.J., Jia, S.S., Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-kappaB/mTOR and ERK1/2 signaling pathways. Biomed. Pharmacother. 83 (2016), 1164–1174.
65. Kim, A., Yim, N.H., Im, M., Jung, Y.P., Kim, T., Ma, J.Y., Suppression of the invasive potential of highly malignant tumor cells by KIOM-C, a novel herbal medicine, via inhibition of NF-kappaB activation and MMP-9 expression. Oncol. Rep. 31 (2014), 287–297.
66. Tan, M.L., Ooi, J.P., Ismail, N., Moad, A.I., Muhammad, T.S., Programmed cell death pathways and current antitumor targets. Pharm. Res. 26 (2009), 1547–1560.
67. Kim, A., Im, M., Yim, N.H., Kim, T., Ma, J.Y., A novel herbal medicine, KIOM-C, induces autophagic and apoptotic cell death mediated by activation of JNK and reactive oxygen species in HT1080 human fibrosarcoma cells. PLoS One, 9, 2014, e98703.
68. Bastola, T., An, R.B., Kim, Y.C., Kim, J., Seo, J., Cearoin induces autophagy, ERK activation and apoptosis via ROS generation in SH-SY5Y neuroblastoma cells. Molecules, 22, 2017.
69. Funakoshi-Tago, M., Okamoto, K., Izumi, R., Tago, K., Yanagisawa, K., Narukawa, Y., Kiuchi, F., Kasahara, T., Tamura, H., Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway. Int. Immunopharm. 25 (2015), 189–198.
70. Sarkar, S., Dutta, D., Samanta, S.K., Bhattacharya, K., Pal, B.C., Li, J., Datta, K., Mandal, C., Mandal, C., Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. Int. J. Canc. 132 (2013), 695–706.
71. Bhattacharya, K., Samanta, S.K., Tripathi, R., Mallick, A., Chandra, S., Pal, B.C., Shaha, C., Mandal, C., Apoptotic effects of mahanine on human leukemic cells are mediated through crosstalk between Apo-1/Fas signaling and the Bid protein and via mitochondrial pathways. Biochem. Pharmacol. 79 (2010), 361–372.
72. Sarkar, S., Dutta, D., Samanta, S.K., Bhattacharya, K., Pal, B.C., Li, J., Datta, K., Mandal, C., Mandal, C., Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo. Int. J. Canc. 132 (2013), 695–706.
73. Utaipan, T., Athipornchai, A., Suksamrarn, A., Jirachotikoon, C., Yuan, X., Lertcanawanichakul, M., Chunglok, W., Carbazole alkaloids from Murraya koenigii trigger apoptosis and autophagic flux inhibition in human oral squamous cell carcinoma cells. J. Nat. Med. 71 (2017), 158–169.
74. Chen, C.M., Syu, J.P., Way, T.D., Huang, L.J., Kuo, S.C., Lin, C.T., Lin, C.L., BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide. Int. J. Mol. Med. 36 (2015), 1244–1252.
75. Yang, J., Wu, W., Wen, J., Ye, H., Luo, H., Bai, P., Tang, M., Wang, F., Zheng, L., Yang, S., Li, W., Peng, A., Yang, L., Wan, L., Chen, L., Liposomal honokiol induced lysosomal degradation of Hsp90 client proteins and protective autophagy in both gefitinib-sensitive and gefitinib-resistant NSCLC cells. Biomaterials 141 (2017), 188–198.
76. Meschini, S., Marra, M., Condello, M., Calcabrini, A., Federici, E., Dupuis, M.L., Cianfriglia, M., Arancia, G., Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. Int. J. Oncol. 27 (2005), 1597–1603.
77. Hsieh, M.J., Lin, C.W., Chiou, H.L., Yang, S.F., Chen, M.K., Correction: dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells. Oncotarget, 8, 2017, 14268.
78. Hsieh, M.J., Lin, C.W., Chiou, H.L., Yang, S.F., Chen, M.K., Dehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells. Oncotarget 6 (2015), 30831–30849.
79. Hsieh, M.J., Chen, J.C., Yang, W.E., Chien, S.Y., Chen, M.K., Lo, Y.S., Hsi, Y.T., Chuang, Y.C., Lin, C.C., Yang, S.F., Dehydroandrographolide inhibits oral cancer cell migration and invasion through NF-kappaB-, AP-1-, and SP-1-modulated matrix metalloproteinase-2 inhibition. Biochem. Pharmacol. 130 (2017), 10–20.
80. Jiang, Q.L., Zhang, S., Tian, M., Zhang, S.Y., Xie, T., Chen, D.Y., Chen, Y.J., He, J., Liu, J., Ouyang, L., Jiang, X., Plant lectins, from ancient sugar-binding proteins to emerging anti-cancer drugs in apoptosis and autophagy. Cell Prolif 48 (2015), 17–28.
81. Wu, L., Liu, T., Xiao, Y., Li, X., Zhu, Y., Zhao, Y., Bao, J., Wu, C., Polygonatum odoratum lectin induces apoptosis and autophagy by regulation of microRNA-1290 and microRNA-15a-3p in human lung adenocarcinoma A549 cells. Int. J. Biol. Macromol. 85 (2016), 217–226.
82. Feng, L.X., Sun, P., Mi, T., Liu, M., Liu, W., Yao, S., Cao, Y.M., Yu, X.L., Wu, W.Y., Jiang, B.H., Yang, M., Guo, D.A., Liu, X., Agglutinin isolated from Arisema heterophyllum Blume induces apoptosis and autophagy in A549 cells through inhibiting PI3K/Akt pathway and inducing ER stress. Chin. J. Nat. Med. 14 (2016), 856–864.
83. Behera, B., Mishra, D., Roy, B., Devi, K.S.P., Narayan, R., Das, J., Ghosh, S.K., Maiti, T.K., Abrus precatorius agglutinin-derived peptides induce ROS-dependent mitochondrial apoptosis through JNK and Akt/P38/P53 pathways in HeLa cells. Chem. Biol. Interact. 222 (2014), 97–105.
84. Panda, P.K., Behera, B., Meher, B.R., Das, D.N., Mukhopadhyay, S., Sinha, N., Naik, P.P., Roy, B., Das, J., Paul, S., Maiti, T.K., Agarwal, R., Bhutia, S.K., Abrus Agglutinin, a type II ribosome inactivating protein inhibits Akt/PH domain to induce endoplasmic reticulum stress mediated autophagy-dependent cell death. Mol. Carcinog. 56 (2017), 389–401.
85. Behera, B., Mishra, D., Roy, B., Devi, K.S., Narayan, R., Das, J., Ghosh, S.K., Maiti, T.K., Abrus precatorius agglutinin-derived peptides induce ROS-dependent mitochondrial apoptosis through JNK and Akt/P38/P53 pathways in HeLa cells. Chem. Biol. Interact. 222 (2014), 97–105.
86. Wu, L., Bao, J.K., Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins. Glycoconj. J. 30 (2013), 269–279.
87. Druz, A., Chen, Y.C., Guha, R., Betenbaugh, M., Martin, S.E., Shiloach, J., Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines. RNA Biol. 10 (2013), 287–300.
88. Mohammad, R.M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.Y., Lin, L.T., Siegelin, M.D., Fimognari, C., Kumar, N.B., Dou, Q.P., Yang, H., Samadi, A.K., Russo, G.L., Spagnuolo, C., Ray, S.K., Chakrabarti, M., Morre, J.D., Coley, H.M., Honoki, K., Fujii, H., Georgakilas, A.G., Amedei, A., Niccolai, E., Amin, A., Ashraf, S.S., Helferich, W.G., Yang, X., Boosani, C.S., Guha, G., Bhakta, D., Ciriolo, M.R., Aquilano, K., Chen, S., Mohammed, S.I., Keith, W.N., Bilsland, A., Halicka, D., Nowsheen, S., Azmi, A.S., Broad targeting of resistance to apoptosis in cancer. Semin. Canc. Biol. 35:Suppl (2015), S78–S103.
89. Proskuryakov, S.Y., Konoplyannikov, A.G., Gabai, V.L., Necrosis: a specific form of programmed cell death?. Exp. Cell Res. 283 (2003), 1–16.
90. Galluzzi, L., Kroemer, G., Necroptosis: a specialized pathway of programmed necrosis. Cell 135 (2008), 1161–1163.
91. Wu, W., Liu, P., Li, J., Necroptosis: an emerging form of programmed cell death. Crit. Rev. Oncol. Hematol. 82 (2012), 249–258.
92. Galluzzi, L., Kepp, O., Chan, F.K., Kroemer, G., Necroptosis: mechanisms and relevance to disease. Annu. Rev. Pathol. 12 (2017), 103–130.
93. Diederich, M., Cerella, C., Non-canonical programmed cell death mechanisms triggered by natural compounds. Semin. Canc. Biol. 40–41 (2016), 4–34.
94. Wallach, D., Kang, T.B., Yang, S.H., Kovalenko, A., The in vivo significance of necroptosis: lessons from exploration of caspase-8 function. Cytokine Growth Factor Rev. 25 (2014), 157–165.
95. Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., Wang, X., Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148 (2012), 213–227.
96. Galluzzi, L., Kepp, O., Kroemer, G., MLKL regulates necrotic plasma membrane permeabilization. Cell Res. 24 (2014), 139–140.
97. Galluzzi, L., Kepp, O., Chan, F.K., Kroemer, G., Necroptosis: mechanisms and relevance to disease. Annu. Rev. Pathol. 12 (2017), 103–130.
98. Stoll, G., Ma, Y., Yang, H., Kepp, O., Zitvogel, L., Kroemer, G., Pro-necrotic molecules impact local immunosurveillance in human breast cancer. OncoImmunology, 6, 2017, e1299302.
99. He, G.W., Gunther, C., Thonn, V., Yu, Y.Q., Martini, E., Buchen, B., Neurath, M.F., Sturzl, M., Becker, C., Regression of apoptosis-resistant colorectal tumors by induction of necroptosis in mice. J. Exp. Med. 214 (2017), 1655–1662.
100. Nugues, A.L., El, B.H., Hetuin, D., Berthon, C., Loyens, A., Bertrand, E., Jouy, N., Idziorek, T., Quesnel, B., RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage. Cell Death Dis., 5, 2014, e1384.
101. Min, R., Tong, J., Wenjun, Y., Wenhu, D., Xiaojian, Z., Jiacai, H., Jian, Z., Wantao, C., Chenping, Z., Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway. Phytother. Res. 22 (2008), 407–415.
102. Fu, Z., Deng, B., Liao, Y., Shan, L., Yin, F., Wang, Z., Zeng, H., Zuo, D., Hua, Y., Cai, Z., The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis. BMC Canc., 13, 2013, 580.
103. Huang, C., Luo, Y., Zhao, J., Yang, F., Zhao, H., Fan, W., Ge, P., Shikonin kills glioma cells through necroptosis mediated by RIP-1. PLoS One, 8, 2013, e66326.
104. Sawai, H., Domae, N., Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/propidium iodide-negative cells. Biochem. Biophys. Res. Commun. 411 (2011), 569–573.
105. Chromik, J., Safferthal, C., Serve, H., Fulda, S., Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis. Canc. Lett. 344 (2014), 101–109.
106. Wada, N., Kawano, Y., Fujiwara, S., Kikukawa, Y., Okuno, Y., Tasaki, M., Ueda, M., Ando, Y., Yoshinaga, K., Ri, M., Iida, S., Nakashima, T., Shiotsu, Y., Mitsuya, H., Hata, H., Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. Int. J. Oncol., 46, 2015, 963.
107. Klayman, D.L., Qinghaosu (artemisinin): an antimalarial drug from China. Science 228 (1985), 1049–1055.
108. Button, R.W., Lin, F., Ercolano, E., Vincent, J.H., Hu, B., Hanemann, C.O., Luo, S., Artesunate induces necrotic cell death in schwannoma cells. Cell Death Dis., 5, 2014, e1466.
109. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B., Stockwell, B.R., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (2012), 1060–1072.
110. Yang, W.S., SriRamaratnam, R., Welsch, M.E., Shimada, K., Skouta, R., Viswanathan, V.S., Cheah, J.H., Clemons, P.A., Shamji, A.F., Clish, C.B., Brown, L.M., Girotti, A.W., Cornish, V.W., Schreiber, S.L., Stockwell, B.R., Regulation of ferroptotic cancer cell death by GPX4. Cell 156 (2014), 317–331.
111. Cao, J.Y., Dixon, S.J., Mechanisms of ferroptosis. Cell. Mol. Life Sci. 73 (2016), 2195–2209.
112. Xie, Y., Song, X., Sun, X., Huang, J., Zhong, M., Lotze, M.T., Zeh, H.R., Kang, R., Tang, D., Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 473 (2016), 775–780.
113. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J., Smith, R., Lessnick, S.L., Sahasrabudhe, S., Stockwell, B.R., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447 (2007), 864–868.
114. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J., Smith, R., Lessnick, S.L., Sahasrabudhe, S., Stockwell, B.R., RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447 (2007), 864–868.
115. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B.R., Stockwell, B.R., Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149 (2012), 1060–1072.
116. Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., Tang, D., Ferroptosis: process and function. Cell Death Differ. 23 (2016), 369–379.
117. Wolpaw, A.J., Shimada, K., Skouta, R., Welsch, M.E., Akavia, U.D., Pe'Er, D., Shaik, F., Bulinski, J.C., Stockwell, B.R., Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), E771–E780.
118. Friedmann, A.J., Schneider, M., Proneth, B., Tyurina, Y.Y., Tyurin, V.A., Hammond, V.J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., Basavarajappa, D., Radmark, O., Kobayashi, S., Seibt, T., Beck, H., Neff, F., Esposito, I., Wanke, R., Forster, H., Yefremova, O., Heinrichmeyer, M., Bornkamm, G.W., Geissler, E.K., Thomas, S.B., Stockwell, B.R., O'Donnell, V.B., Kagan, V.E., Schick, J.A., Conrad, M., Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16 (2014), 1180–1191.
119. Vigil, D., Cherfils, J., Rossman, K.L., Der, C.J., Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?. Nat. Rev. Canc. 10 (2010), 842–857.
120. Donald, G., Hertzer, K., Eibl, G., Baicalein–an intriguing therapeutic phytochemical in pancreatic cancer. Curr. Drug Targets 13 (2012), 1772–1776.
121. Probst, L., Dachert, J., Schenk, B., Fulda, S., Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death. Biochem. Pharmacol. 140 (2017), 41–52.
122. Schott, C., Graab, U., Cuvelier, N., Hahn, H., Fulda, S., Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death. Front. Oncol., 5, 2015, 131.
123. Schott, C., Graab, U., Cuvelier, N., Hahn, H., Fulda, S., Oncogenic RAS mutants confer resistance of RMS13 rhabdomyosarcoma cells to oxidative stress-induced ferroptotic cell death. Front. Oncol., 5, 2015, 131.
124. Jiang, L., Kon, N., Li, T., Wang, S.J., Su, T., Hibshoosh, H., Baer, R., Gu, W., Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520 (2015), 57–62.
125. Imai, H., Nakagawa, Y., Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic. Biol. Med. 34 (2003), 145–169.
126. Viswanathan, V.S., Ryan, M.J., Dhruv, H.D., Gill, S., Eichhoff, O.M., Seashore-Ludlow, B., Kaffenberger, S.D., Eaton, J.K., Shimada, K., Aguirre, A.J., Viswanathan, S.R., Chattopadhyay, S., Tamayo, P., Yang, W.S., Rees, M.G., Chen, S., Boskovic, Z.V., Javaid, S., Huang, C., Wu, X., Tseng, Y., Roider, E.M., Gao, D., Cleary, J.M., Wolpin, B.M., Mesirov, J.P., Haber, D.A., Engelman, J.A., Boehm, J.S., Kotz, J.D., Hon, C.S., Chen, Y., Hahn, W.C., Levesque, M.P., Doench, J.G., Berens, M.E., Shamji, A.F., Clemons, P.A., Stockwell, B.R., Schreiber, S.L., Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547 (2017), 453–457.
127. Doll, S., Proneth, B., Tyurina, Y.Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., Prokisch, H., Trümbach, D., Mao, G., Qu, F., Bayir, H., Füllekrug, J., Scheel, C.H., Wurst, W., Schick, J.A., Kagan, V.E., Angeli, J.P.F., Conrad, M., ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13 (2016), 91–98.
128. Kasukabe, T., Honma, Y., Okabe-Kado, J., Higuchi, Y., Kato, N., Kumakura, S., Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells. Oncol. Rep. 36 (2016), 968–976.
129. Jutooru, I., Guthrie, A.S., Chadalapaka, G., Pathi, S., Kim, K., Burghardt, R., Jin, U.H., Safe, S., Mechanism of action of phenethylisothiocyanate and other reactive oxygen species-inducing anticancer agents. Mol. Cell Biol. 34 (2014), 2382–2395.
130. Efferth, T., Rucker, G., Falkenberg, M., Manns, D., Olbrich, A., Fabry, U., Osieka, R., Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 46 (1996), 196–200.
131. Efferth, T., Giaisi, M., Merling, A., Krammer, P.H., Li-Weber, M., Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One, 2, 2007, e693.
132. Efferth, T., Oesch, F., Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Biochem. Pharmacol. 68 (2004), 3–10.
133. Ooko, E., Saeed, M.E.M., Kadioglu, O., Sarvi, S., Colak, M., Elmasaoudi, K., Janah, R., Greten, H.J., Efferth, T., Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine 22 (2015), 1045–1054.
134. Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., Brady, N.R., Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2 (2015), 517–532.
135. Efferth, T., Benakis, A., Romero, M.R., Tomicic, M., Rauh, R., Steinbach, D., Hafer, R., Stamminger, T., Oesch, F., Kaina, B., Marschall, M., Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic. Biol. Med. 37 (2004), 998–1009.
136. Badea, L., Herlea, V., Dima, S.O., Dumitrascu, T., Popescu, I., Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepato-Gastroenterol. 55 (2008), 2016–2027.
137. Xie, Y., et al. Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 473 (2016), 775–780.
138. Xie, Y., Song, X., Sun, X., Huang, J., Zhong, M., Lotze, M.T., Zeh, H.R., Kang, R., Tang, D., Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochem. Biophys. Res. Commun. 473 (2016), 775–780.
139. Sun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., Tang, D., Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63 (2016), 173–184.
140. Miao, E.A., Leaf, I.A., Treuting, P.M., Mao, D.P., Dors, M., Sarkar, A., Warren, S.E., Wewers, M.D., Aderem, A., Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat. Immunol. 11 (2010), 1136–1142.
141. Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., Shao, F., Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547 (2017), 99–103.
142. Jorgensen, I., Miao, E.A., Pyroptotic cell death defends against intracellular pathogens. Immunol. Rev. 265 (2015), 130–142.
143. Sborgi, L., Ruhl, S., Mulvihill, E., Pipercevic, J., Heilig, R., Stahlberg, H., Farady, C.J., Muller, D.J., Broz, P., Hiller, S., GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 35 (2016), 1766–1778.
144. Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q.T., Liu, P.S., Lill, J.R., Li, H., Wu, J., Kummerfeld, S., Zhang, J., Lee, W.P., Snipas, S.J., Salvesen, G.S., Morris, L.X., Fitzgerald, L., Zhang, Y., Bertram, E.M., Goodnow, C.C., Dixit, V.M., Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
145. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., Shao, F., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
146. Qi, X., Formation of membrane pores by gasdermin-N causes pyroptosis. Sci. China Life Sci. 59 (2016), 1071–1073.
147. Li, Y., Zhu, B., Genotypes and phenotypes of a family with a deaf child carrying combined heterozygous mutations in SLC26A4 and GJB3 genes. Mol. Med. Rep. 14 (2016), 319–324.
148. Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., Shao, F., Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature 547 (2017), 99–103.
149. Kim, M.S., Chang, X., Yamashita, K., Nagpal, J.K., Baek, J.H., Wu, G., Trink, B., Ratovitski, E.A., Mori, M., Sidransky, D., Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma. Oncogene 27 (2008), 3624–3634.
150. Villar, V.H., Merhi, F., Djavaheri-Mergny, M., Duran, R.V., Glutaminolysis and Autophagy in Cancer. 2015.
151. Zhao, Y., Butler, E.B., Tan, M., Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis., 4, 2013, e532.
152. Cetindis, M., Biegner, T., Munz, A., Teriete, P., Reinert, S., Grimm, M., Glutaminolysis and carcinogenesis of oral squamous cell carcinoma. Eur. Arch. Oto-Rhino-Laryngol. 273 (2016), 495–503.
153. Yang, J., Chi, Y., Burkhardt, B.R., Guan, Y., Wolf, B.A., Leucine metabolism in regulation of insulin secretion from pancreatic beta cells. Nutr. Rev. 68 (2010), 270–279.
154. Cervantes-Madrid, D., Romero, Y., Dueñas-González, A., Reviving lonidamine and 6-Diazo-5-oxo-L-norleucine to Be used in combination for metabolic cancer therapy. BioMed Res. Int. 2015 (2015), 1–13.
155. Guo, L., Zhou, B., Liu, Z., Xu, Y., Lu, H., Xia, M., Guo, E., Shan, W., Chen, G., Wang, C., Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling. Tumor Biol. 37 (2016), 11007–11015.
156. Hsieh, A.L., Walton, Z.E., Altman, B.J., Stine, Z.E., Dang, C.V., MYC and metabolism on the path to cancer. Semin. Cell Dev. Biol. 43 (2015), 11–21.
157. Hsieh, A.L., Walton, Z.E., Altman, B.J., Stine, Z.E., Dang, C.V., MYC and metabolism on the path to cancer. Semin. Cell Dev. Biol. 43 (2015), 11–21.
158. Freeman, M.R., Kim, J., Lisanti, M.P., Di Vizio, D., A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death. Canc. Biol. Ther. 12 (2011), 966–977.
159. Avissar, N.E., Sax, H.C., Toia, L., In human entrocytes, GLN transport and ASCT2 surface expression induced by short-term EGF are MAPK, PI3K, and Rho-dependent. Dig. Dis. Sci. 53 (2008), 2113–2125.
160. Lin, X., Farooqi, A.A., Ismail, M., Recent progress in fungus-derived bioactive agents for targeting of signaling machinery in cancer cells. Drug Des. Dev. Ther. 9 (2015), 1797–1804.
161. Lin, C.Y., Loven, J., Rahl, P.B., Paranal, R.M., Burge, C.B., Bradner, J.E., Lee, T.I., Young, R.A., Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151 (2012), 56–67.
162. Sharma, S.H., Thulasingam, S., Chellappan, D.R., Chinnaswamy, P., Nagarajan, S., Morin and Esculetin supplementation modulates c-myc induced energy metabolism and attenuates neoplastic changes in rats challenged with the procarcinogen 1,2-dimethylhydrazine. Eur. J. Pharmacol. 796 (2017), 20–31.
163. Villar, V.H., Duran, R.V., Glutamoptosis: a new cell death mechanism inhibited by autophagy during nutritional imbalance. Autophagy 13 (2017), 1078–1079.
164. Denzer, K., Kleijmeer, M.J., Heijnen, H.F., Stoorvogel, W., Geuze, H.J., Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113:Pt 19 (2000), 3365–3374.
165. Nolte-'T, H.E., Buermans, H.P., Waasdorp, M., Stoorvogel, W., Wauben, M.H., T, H.P., Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res. 40 (2012), 9272–9285.
166. Zhang, L., Zhang, S., Yao, J., Lowery, F.J., Zhang, Q., Huang, W., Li, P., Li, M., Wang, X., Zhang, C., Wang, H., Ellis, K., Cheerathodi, M., McCarty, J.H., Palmieri, D., Saunus, J., Lakhani, S., Huang, S., Sahin, A.A., Aldape, K.D., Steeg, P.S., Yu, D., Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527 (2015), 100–104.
167. Ha, D., Yang, N., Nadithe, V., Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharm. Sin. B 6 (2016), 287–296.
168. Wu, C.Y., Du, S.L., Zhang, J., Liang, A.L., Liu, Y.J., Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment. Canc. Gene Ther. 24 (2017), 6–12.
169. Zhou, Y., Tian, T., Zhu, Y., Jaffar, A.D., Hu, F., Qi, Y., Sun, B., Xiao, Z., Exosomes transfer among different species cells and mediating miRNAs delivery. J. Cell. Biochem. 118 (2017), 4267–4274.
170. Otsuka, K., Yamamoto, Y., Matsuoka, R., Ochiya, T., Maintaining good miRNAs in the body keeps the doctor away?: Perspectives on the relationship between food-derived natural products and microRNAs in relation to exosomes/extracellular vesicles. Mol. Nutr. Food Res., 62, 2018, 10.1002/mnfr.201700080.
171. Gernapudi, R., Yao, Y., Zhang, Y., Wolfson, B., Roy, S., Duru, N., Eades, G., Yang, P., Zhou, Q., Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Canc. Res. Treat. 150 (2015), 685–695.
172. Khan, I.N., Ullah, N., Hussein, D., Saini, K.S., Current and emerging biomarkers in tumors of the central nervous system: possible diagnostic, prognostic and therapeutic applications. Semin. Canc. Biol., 2017, 10.1016/j.semcancer.2017.07.004 pii: S1044-579X(17)30114-1.
173. Ma, W., Xu, M., Liu, Y., Liu, H., Huang, J., Zhu, Y., Ji, L.J., Qi, X., Safety profile of combined therapy inhibiting EFGR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 15 phase II/III randomized trials. Int. J. Canc. 137 (2015), 409–419.
174. Kamerkar, S., LeBleu, V.S., Sugimoto, H., Yang, S., Ruivo, C.F., Melo, S.A., Lee, J.J., Kalluri, R., Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 546 (2017), 498–503.
175. Lee, J.K., Park, S.R., Jung, B.K., Jeon, Y.K., Lee, Y.S., Kim, M.K., Kim, Y.G., Jang, J.Y., Kim, C.W., Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One, 8, 2013, e84256.
176. Jaiswal, S., Jamieson, C.H., Pang, W.W., Park, C.Y., Chao, M.P., Majeti, R., Traver, D., van Rooijen, N., Weissman, I.L., CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell 138 (2009), 271–285.
177. Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.D., Song, E., Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Canc., 10, 2011, 117.
178. Delort, L., Lequeux, C., Dubois, V., Dubouloz, A., Billard, H., Mojallal, A., Damour, O., Vasson, M.P., Caldefie-Chezet, F., Reciprocal interactions between breast tumor and its adipose microenvironment based on a 3D adipose equivalent model. PLoS One, 8, 2013, e66284.
179. Kang, K.S., Wang, P., Yamabe, N., Fukui, M., Jay, T., Zhu, B.T., Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One, 5, 2010, e10296.
180. Rose, D.P., Connolly, J.M., Antiangiogenicity of docosahexaenoic acid and its role in the suppression of breast cancer cell growth in nude mice. Int. J. Oncol. 15 (1999), 1011–1015.
181. Hannafon, B.N., Carpenter, K.J., Berry, W.L., Janknecht, R., Dooley, W.C., Ding, W.Q., Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA). Mol. Canc., 14, 2015, 133.